Orthogonally redundant sensor systems and methods
View Patent ↗A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.
1. A continuous glucose monitoring system comprising:
an orthogonally redundant glucose sensor, comprising:
an optical glucose sensor including a lightguide on a first respective substrate and having a distal portion configured for internal placement in a body of a user; and
a non-optical glucose sensor including at least one electrode on a second respective substrate and having a distal portion configured for internal placement in the user's body,
wherein said first and second respective substrates are integrated into an integrated flex circuit, and wherein said lightguide is disposed in an interior of said integrated flex circuit and said at least one electrode is disposed on an external surface of said integrated flex circuit;
an insertion device including an insertion needle, wherein said integrated flex circuit is configured to be carried inside said needle for simultaneous insertion of said optical glucose sensor and said non-optical glucose sensor into the user's body; and
an external transmitter.
2. The system of claim 1 , wherein the non-optical glucose sensor is an electrochemical glucose sensor.
3. The system of claim 2 , wherein the electrochemical glucose sensor includes a plurality of electrodes.
4. The system of claim 1 , wherein the transmitter includes instrumentation in said housing configured to receive an optical signal from the optical sensor and a non-optical signal from the non-optical sensor and configured to convert each of said optical and non-optical signals to respective glucose values.
5. The system of claim 4 , wherein the transmitter is configured to wirelessly transmit said respective glucose values.
6. The system of claim 1 , wherein said lightguide is an optical fiber having said distal portion for internal placement in the user's body and a proximal portion that is disposed externally to the user's body.
7. The system of claim 6 , further including a glucose-permeable membrane, wherein the membrane has a closed end, a hollow interior, and an open end that is coupled to the optical fiber's distal portion.
8. The system of claim 6 , wherein the proximal portion of the optical fiber is optically coupled to an assay interrogating system.
9. The system of claim 8 , wherein the assay interrogating system is an optoelectronic interrogating system.
10. The system of claim 8 , wherein the interrogating system is a stacked planar integrated optical system (SPIOS).
11. The system of claim 6 , wherein the optical fiber has a circular cross-section having a diameter of between 200 μm and 500 μm.
12. The system of claim 1 , wherein the optical glucose sensor has at least one failure mode, the non-optical glucose sensor has at least one failure mode, and the at least one failure mode of the optical glucose sensor is different from the at least one failure mode of the non-optical glucose sensor.
13. The system of claim 1 , further including a hand-held monitor, wherein the handheld monitor includes an integrated blood glucose meter.
14. The system of claim 13 , wherein the hand-held monitor further includes a display.
15. The system of claim 1 , further including an insulin pump.
16. The system of claim 15 , wherein the transmitter wirelessly communicates with the insulin pump.
17. The system of claim 1 , wherein said glucose monitoring system is a closed-loop system.
18. The system of claim 7 , wherein the optical glucose sensor includes an assay having a glucose receptor, a glucose analog, and a first fluorophore.
19. The system of claim 18 , wherein the assay is housed in an assay compartment defined within the membrane's hollow interior and between the optical fiber's distal portion and the membrane's closed end.
20. The system of claim 19 , wherein the assay compartment is placed within the user's tissue.
21. The system of claim 20 , wherein the membrane is biodegradable.
22. The system of claim 18 , wherein the first fluorophore is water soluble.
23. The system of claim 1 , wherein the respective distal portions of the optical sensor and the non-optical sensor are co-located within the user's body.